CIRS / Mold Illness

A water-damaged building can affect more than the nose Chronic Inflammatory Response Syndrome, commonly called CIRS, is a clinical framework used to describe a persistent, multisystem inflammatory response associated with exposure to biotoxins, often from a water-damaged building, in a susceptible individual. Patients may also have mold allergy, asthma, mast-cell activation, fungal colonization, or another illness, but those are separate diagnoses that require separate reasoning.

CIRS is not defined by sneezing

Mold allergy often causes nasal congestion, sneezing, itchy or watery eyes, cough, wheezing, or hives. CIRS may include some of those symptoms, but the broader picture can involve the brain, autonomic nervous system, immune system, endocrine regulation, gastrointestinal tract, pain pathways, and energy production.

The pattern is usually recognized through a combination of:

• A credible exposure history.
• Multisystem symptoms.
• A timeline showing worsening in a particular environment or after water damage.
• Evidence of inflammatory or physiologic dysregulation when present.
• Improvement with exposure reduction and appropriately selected treatment.
• Exclusion of other conditions that better explain the presentation.

What CIRS / mold illness can look like

Cognitive and neurologic symptoms

• Brain fog, poor focus, memory problems, slowed processing, or word-finding difficulty.
• Headache, head pressure, light sensitivity, sound sensitivity, dizziness, disequilibrium, or motion sensitivity.
• Numbness, tingling, unusual “electric” sensations, tremor, weakness, or poor coordination.
• Sleep disruption, vivid dreams, reversed sleep cycle, or unrefreshing sleep.

Neuropsychiatric and developmental symptoms

• Anxiety, panic-like episodes, irritability, depression, emotional lability, or rage.
• Worsening OCD, tics, intrusive thoughts, attention problems, or sensory reactivity.
• Cognitive regression, loss of school skills, decreased language access, or worsening autistic function.
• Dissociation, confusion, or psychosis-like symptoms in severe or overlapping illness, after other causes are considered.

Autonomic and whole-body symptoms

• Severe fatigue, weakness, exercise intolerance, or post-exertional worsening.
• Dizziness, racing heart, faintness, POTS-like symptoms, temperature intolerance, or unusual sweating.
• Air hunger, cough, chest tightness, sinus symptoms, congestion, or recurrent throat clearing.
• Joint, muscle, bone, abdominal, or migratory pain.
• Temperature swings, night sweats, chills, or feeling flu-like.
• Rashes, itching, flushing, unusual bruising, swelling, static-shock sensations, or chemical sensitivity.
• Nausea, reflux, abdominal pain, constipation, diarrhea, appetite changes, or food reactivity.

These symptoms are not specific to CIRS.

The pattern, exposure history, and differential diagnosis matter. A checklist without a timeline is merely a very anxious grocery list.

Exposure clues

• Known roof, plumbing, basement, crawl-space, window, foundation, or HVAC water damage.
• Musty odor, visible mold, condensation, recurrent leaks, warped material, or prior flooding.
• Mold hidden behind walls, under flooring, in insulation, attics, ductwork, cabinets, or wall cavities.
• Symptoms that improve at school, outdoors, on vacation, or after leaving the building.
• Symptoms that worsen after returning home, turning on heating or air conditioning, entering a basement, or disturbing stored belongings.
• Multiple family members or pets with new symptoms in the same environment.
• A history of incomplete remediation, painting over damage, fogging without source removal, or repeatedly cleaning visible growth while moisture continues.

Why only some people become ill

Susceptibility varies. Genetics, HLA patterns, prior immune stress, infection history, mast-cell reactivity, age, nutritional status, dose and duration of exposure, and the mixture of organisms and contaminants may all influence response. HLA or other susceptibility testing may be informative in selected cases, but it does not diagnose CIRS by itself and does not prove that a building is unsafe.

How we evaluate suspected CIRS

1. Environmental and symptom timeline

We ask where the child lived, attended school, slept, spent weekends, and improved or worsened. We review leaks, flooding, HVAC issues, odor, remediation, storage, and whether other family members are affected.

2. Building evaluation

Depending on the situation, useful tools may include a qualified visual inspection, moisture mapping, targeted sampling, dust-based testing such as ERMI or HERTSMI-type methods, HVAC assessment, and review of prior remediation. No single environmental score replaces inspection and context.

3. Medical differential diagnosis

We consider mold allergy, asthma, infection, anemia, thyroid disease, sleep disorders, migraine, seizures, autoimmune disease, tick-borne illness, mast-cell activation, POTS, medication effects, nutritional deficiency, and psychiatric conditions. Finding mold does not exempt us from practicing ordinary medicine.

4. Targeted laboratory evaluation

Testing may include basic medical laboratories, inflammatory or immune markers, allergy testing when indicated, complement or other CIRS-associated markers in selected cases, HLA susceptibility testing, osmolality or endocrine-related studies when clinically relevant, mycotoxin testing used cautiously, mold-specific antibodies, and assessment for overlapping infection, MCAS, or dysautonomia.

KEY MESSAGE

No urine mycotoxin result, mold IgG result, HLA type, complement marker, or building test independently proves the entire diagnosis. These are pieces of a clinical puzzle, not judicial verdicts.

Treatment approach

Stop or reduce ongoing exposure

Treatment is much harder when the patient remains in a significantly contaminated environment. The practical options may include source repair, professional remediation, temporary relocation, changing the sleeping area, removing damaged belongings, or other exposure-reduction steps based on the severity and resources of the family.

Remediate correctly

Effective remediation generally requires finding and correcting the moisture source, removing contaminated porous material safely, controlling dust, cleaning the affected area and contents appropriately, and verifying that conditions improved. Painting over a wet wall is not remediation; it is interior decorating with denial.

Reduce inflammatory and toxin recirculation load

Selected patients may benefit from binders such as cholestyramine, charcoal, clay, or other agents, chosen according to tolerance and treatment goals. Binders can worsen constipation and interfere with medications or nutrients, so timing, hydration, bowel function, and monitoring matter.

Address mast-cell and autonomic amplification

H1 and H2 blockers, mast-cell stabilizers, hydration, electrolytes, salt, sleep treatment, and other individualized supports may reduce the body's overreaction while the primary exposure is addressed.

Treat fungal colonization or infection only when clinically supported

Some patients may have sinus, nasal, gastrointestinal, skin, or other fungal colonization, and a smaller group may have true fungal infection. Antifungal treatment is not automatically required merely because a building contains mold or a urine test detects a metabolite. Site, symptoms, testing, immune status, and risk matter.

Support elimination and recovery

Constipation prevention, hydration, adequate nutrition, sleep, gradual activity, treatment of nutrient deficiency, and selected liver or antioxidant support may help the child tolerate treatment. “Detox” should not mean making a fragile child sicker in order to prove the protocol is working.

What improvement may look like

• Clearer thinking and better access to language or school skills.
• Less headache, dizziness, light sensitivity, or sensory overload.
• More stable sleep, mood, heart rate, digestion, and energy.
• Reduced OCD, tics, anxiety, rage, or regression.
• Fewer reactions to foods, odors, heat, or exertion.
• Improved resilience to infections and other triggers.
• Improvement after leaving an environment is clinically useful information, but it is not the only evidence considered.
• Recovery may lag behind exposure reduction, especially when the illness has been prolonged or there are overlapping infections, MCAS, POTS, or nutritional problems.

SAFETY

Trouble breathing, severe asthma, syncope, dehydration, rapidly progressive weakness, seizures, confusion, suicidal risk, psychosis, or suspected invasive fungal infection requires urgent conventional medical assessment.

Related pages

Mold Allergy vs. CIRS | Mast Cell Activation | POTS / Dysautonomia | Autism and Regression | Evaluation | Treatment Approach